|
Benitec Australia Limited, based in Queensland, Australia, has key
Intellectual Property in the field of gene silencing using DNA
constructs to trigger RNA interference (granted patents include US
6,573,099; GB 2353282; AU 2001100608). The Company was the first to
demonstrate RNA interference, a universal gene silencing mechanism, in
mammalian and human cells. This natural mechanism is now recognized
worldwide as the simplest and most precise method for shutting down the
activity of any specific gene. The technology is immediately applicable
to functional genomics and the identification and validation of drug
targets. Benitec's technology can also be applied to the treatment of
major human diseases such as cancers, autoimmune disorders and viral
infections through the shutting down of disease-causative genes.
Other applications include plant improvement
and the breeding of viral resistant livestock. Benitec offers customers
licences to undertake research and development on its expanding
technology platform and tools to deliver the technology's full
capability. |
